Author: Hua, Xiaoyang; Vijay, Rahul; Channappanavar, Rudragouda; Athmer, Jeremiah; Meyerholz, David K; Pagedar, Nitin; Tilley, Stephen; Perlman, Stanley
Title: Nasal priming by a murine coronavirus provides protective immunity against lethal heterologous virus pneumonia. Cord-id: io6f6z3l Document date: 2018_1_1
ID: io6f6z3l
Snippet: The nasal mucosa is an important component of mucosal immunity. Immunogenic particles in inspired air are known to activate the local nasal mucosal immune system and can lead to sinonasal inflammation; however, little is known about the effect of this activation on the lung immune environment. Here, we showed that nasal inoculation of murine coronavirus (CoV) in the absence of direct lung infection primes the lung immune environment by recruiting activated monocytes (Ly6C+ inflammatory monocytes
Document: The nasal mucosa is an important component of mucosal immunity. Immunogenic particles in inspired air are known to activate the local nasal mucosal immune system and can lead to sinonasal inflammation; however, little is known about the effect of this activation on the lung immune environment. Here, we showed that nasal inoculation of murine coronavirus (CoV) in the absence of direct lung infection primes the lung immune environment by recruiting activated monocytes (Ly6C+ inflammatory monocytes) and NK cells into the lungs. Unlike infiltration of these cells into directly infected lungs, a process that requires type I IFN signaling, nasally induced infiltration of Ly6C+ inflammatory monocytes into the lungs is IFN-I independent. These activated macrophages ingested antigen and migrated to pulmonary lymph nodes, and enhanced both innate and adaptive immunity after heterologous virus infection. Clinically, such nasal-only inoculation of MHV-1 failed to cause pneumonia but significantly reduced mortality and morbidity of lethal pneumonia caused by severe acute respiratory syndrome CoV (SARS-CoV) or influenza A virus. Together, the data indicate that the nose and upper airway remotely prime the lung immunity to protect the lungs from direct viral infections.
Search related documents:
Co phrase search for related documents- acute sars cov respiratory syndrome cov and adaptive innate immunity: 1, 2
- acute sars cov respiratory syndrome cov and lung immune: 1, 2, 3, 4
- acute sars cov respiratory syndrome cov and lung immunity: 1, 2
- acute sars cov respiratory syndrome cov and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute sars cov respiratory syndrome cov and lymph node: 1
- adaptive innate and lung immune: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- adaptive innate and lung immune environment: 1
- adaptive innate and lung immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- adaptive innate and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- adaptive innate and lung protect: 1
- adaptive innate and lymph node: 1, 2, 3, 4, 5, 6, 7, 8
- adaptive innate immunity and lung immune: 1, 2, 3
- adaptive innate immunity and lung immunity: 1, 2, 3, 4, 5
- adaptive innate immunity and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- adaptive innate immunity and lung protect: 1
- adaptive innate immunity and lymph node: 1, 2, 3, 4
- lung immune and lymph node: 1, 2, 3, 4, 5
- lung infection and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
Co phrase search for related documents, hyperlinks ordered by date